SK pharmteco today announced the successful conclusion of a regulatory inspection of its small molecule North America facility in La Porte, Texas. The U.S. Food and Drug Administration (FDA) carried ...
Understand the challenges of liquid injectables and discover strategies to prevent stability issues and regulatory delays.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results